Compile Data Set for Download or QSAR
Report error Found 599 of affinity data for UniProtKB/TrEMBL: P03138
TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289769(US10093673, Compound 1.1)
Affinity DataEC50:  0.100nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM246811(cis-10-methoxy-11-(3-methoxypropoxy)-3,3-dimethyl-...)
Affinity DataEC50:  13nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM246810(trans-10-methoxy-11-(3-methoxypropoxy)-3,3-dimethy...)
Affinity DataEC50:  460nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289772(US10093673, Compound 3.1)
Affinity DataEC50:  0.300nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289773(US10093673, Compound 3.2)
Affinity DataEC50:  740nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289774(US10093673, Compound 4.1)
Affinity DataEC50:  0.300nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289775(US10093673, Compound 5.1)
Affinity DataEC50:  6nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289776(US10093673, Compound 5.2)
Affinity DataEC50:  0.100nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289777(US10093673, Compound 6.1 | US10093673, Compound 6....)
Affinity DataEC50:  9nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289777(US10093673, Compound 6.1 | US10093673, Compound 6....)
Affinity DataEC50:  5nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289779(US10093673, Compound 7.1)
Affinity DataEC50:  0.800nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289780(US10093673, Compound 7.2)
Affinity DataEC50:  90nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289781(US10093673, Compound 8.1)
Affinity DataEC50:  1nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289782(US10093673, Compound 9.1 | US10093673, Compound 9....)
Affinity DataEC50:  9nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM289782(US10093673, Compound 9.1 | US10093673, Compound 9....)
Affinity DataEC50:  303nMAssay Description:HepG2-Clone42 cells were seeded in into black clear-bottom 96-well plates at a concentration of 6.0×104 cells/well. 24 hours post-seeding, the cells ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519975(US11142527, Example 1)
Affinity DataEC50:  8.45nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519976(US11142527, Example 2)
Affinity DataEC50:  10.4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519977(US11142527, Example 4)
Affinity DataEC50:  19.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519978(US11142527, Example 6)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519979(US11142527, Example 7)
Affinity DataEC50:  8.78nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519980(US11142527, Example 10)
Affinity DataEC50:  19.9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519981(US11142527, Example 11)
Affinity DataEC50:  32.5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519982(US11142527, Example 12)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519983(4-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  22.1nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519984(4-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  22.7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519985(4-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  10.8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519986(3-((6-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(...)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519987(2-(4-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519988(2-(4′-((S)-7-(((R)-6-(2-chloro-4-fluoropheny...)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519989(2-(4-(6-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519990(3-((R)-4-(4-((S)-7-(((R)-6-(2-chloro-4-fluoropheny...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519991(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519992(US11142527, Example 22)
Affinity DataEC50:  18nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519993(4-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519994((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  1nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519995(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519996(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519997(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519998(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM519999(1-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  16nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520000(1-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520001(4′-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520002(4′-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520003(4′-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520004(3-(4-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5...)
Affinity DataEC50:  22nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520005((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  12.1nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520006(US11142527, Example 38)
Affinity DataEC50:  7.10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520007(US11142527, Example 39)
Affinity DataEC50:  6.60nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520008(US11142527, Example 40)
Affinity DataEC50:  8.20nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLarge envelope protein(HBV-D)
Novartis

US Patent
LigandPNGBDBM520009(US11142527, Example 41)
Affinity DataEC50:  5.10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 599 total ) | Next | Last >>
Jump to: